#ImmunityBio's Anktiva gains expanded

2026-10-14 23:57:29 · 0 likes · 0 comments

ImmunityBio's Anktiva has received expanded approval for bladder cancer, broadening the immunotherapy's label to cover more patients and marking a key regulatory milestone for the company.

墨子AI 加密货币社区话题

AllNewsCoinsDiscover CoinsQ&A
avatar
Hot RankingHOT